145 related articles for article (PubMed ID: 30844736)
1. ----Delivery of siRNA therapeutics: PLGA nanoparticles approach.
Matta J; Maalouf R
Front Biosci (Schol Ed); 2019 Mar; 11(1):56-74. PubMed ID: 30844736
[TBL] [Abstract][Full Text] [Related]
2. SiRNA drug delivery by biodegradable polymeric nanoparticles.
Yuan X; Li L; Rathinavelu A; Hao J; Narasimhan M; He M; Heitlage V; Tam L; Viqar S; Salehi M
J Nanosci Nanotechnol; 2006; 6(9-10):2821-8. PubMed ID: 17048488
[TBL] [Abstract][Full Text] [Related]
3. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
[TBL] [Abstract][Full Text] [Related]
4. Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach.
Lokras A; Foged C; Thakur A
Methods Mol Biol; 2021; 2282():137-157. PubMed ID: 33928574
[TBL] [Abstract][Full Text] [Related]
5. Intra-articular controlled release of anti-inflammatory siRNA with biodegradable polymer microparticles ameliorates temporomandibular joint inflammation.
Mountziaris PM; Tzouanas SN; Sing DC; Kramer PR; Kasper FK; Mikos AG
Acta Biomater; 2012 Oct; 8(10):3552-60. PubMed ID: 22750740
[TBL] [Abstract][Full Text] [Related]
6. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.
Su WP; Cheng FY; Shieh DB; Yeh CS; Su WC
Int J Nanomedicine; 2012; 7():4269-83. PubMed ID: 22904633
[TBL] [Abstract][Full Text] [Related]
7. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
Xu C; Liu W; Hu Y; Li W; Di W
Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
[TBL] [Abstract][Full Text] [Related]
8. Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical.
Svenson S; Case RI; Cole RO; Hwang J; Kabir SR; Lazarus D; Lim Soo P; Ng PS; Peters C; Shum P; Sweryda-Krawiec B; Tripathi S; van der Poll D; Eliasof S
Mol Pharm; 2016 Mar; 13(3):737-47. PubMed ID: 26835715
[TBL] [Abstract][Full Text] [Related]
9. Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy.
Nguyen J; Steele TW; Merkel O; Reul R; Kissel T
J Control Release; 2008 Dec; 132(3):243-51. PubMed ID: 18619502
[TBL] [Abstract][Full Text] [Related]
10. Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection.
Steinbach JM; Weller CE; Booth CJ; Saltzman WM
J Control Release; 2012 Aug; 162(1):102-10. PubMed ID: 22705461
[TBL] [Abstract][Full Text] [Related]
11. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM
Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698
[TBL] [Abstract][Full Text] [Related]
12. hTERT-molecular targeted therapy of ovarian cancer cells via folate-functionalized PLGA nanoparticles co-loaded with MNPs/siRNA/wortmannin.
Ghareghomi S; Ahmadian S; Zarghami N; Hemmati S
Life Sci; 2021 Jul; 277():119621. PubMed ID: 34004255
[TBL] [Abstract][Full Text] [Related]
13. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery.
Rafiei P; Haddadi A
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109950. PubMed ID: 31499976
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles Based on Novel Carbohydrate-Functionalized Polymers.
Raposo CD; Conceição CA; Barros MT
Molecules; 2020 Apr; 25(7):. PubMed ID: 32290160
[TBL] [Abstract][Full Text] [Related]
15. Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer.
Hasan W; Chu K; Gullapalli A; Dunn SS; Enlow EM; Luft JC; Tian S; Napier ME; Pohlhaus PD; Rolland JP; DeSimone JM
Nano Lett; 2012 Jan; 12(1):287-92. PubMed ID: 22165988
[TBL] [Abstract][Full Text] [Related]
16. Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics.
Ding D; Zhu Q
Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():1041-1060. PubMed ID: 30184728
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
[TBL] [Abstract][Full Text] [Related]
18. Polymers in small-interfering RNA delivery.
Singha K; Namgung R; Kim WJ
Nucleic Acid Ther; 2011 Jun; 21(3):133-47. PubMed ID: 21749290
[TBL] [Abstract][Full Text] [Related]
19. Image-Guided Nanoparticle-Based siRNA Delivery for Cancer Therapy.
Kim YD; Park TE; Singh B; Maharjan S; Cho KS; Park KP; Choi YJ; Arote RB; Cho CS
Curr Pharm Des; 2015; 21(31):4637-56. PubMed ID: 26486148
[TBL] [Abstract][Full Text] [Related]
20. Polymeric nanoparticles for siRNA delivery: Production and applications.
Cavallaro G; Sardo C; Craparo EF; Porsio B; Giammona G
Int J Pharm; 2017 Jun; 525(2):313-333. PubMed ID: 28416401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
